The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review.

COVID-19 Coronavirus Disinfection Infection control Systematic review Ultraviolet rays light-emitting technology

Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 24 03 2021
revised: 11 05 2021
accepted: 13 05 2021
pubmed: 25 5 2021
medline: 6 8 2021
entrez: 24 5 2021
Statut: ppublish

Résumé

The ongoing pandemic of COVID-19 has underlined the importance of adopting effective infection prevention and control (IPC) measures in hospital and community settings. Ultraviolet (UV)-based technologies represent promising IPC tools: their effective application for sanitation has been extensively evaluated in the past but scant, heterogeneous and inconclusive evidence is available on their effect on SARS-CoV-2 transmission. With the aim of pooling the available evidence on the efficacy of UV technologies against coronaviruses, we conducted a systematic review following PRISMA guidelines, searching Medline, Embase and the Cochrane Library, and the main clinical trials' registries (WHO ICTRP, ClinicalTrials.gov, Cochrane and EU Clinical Trial Register). Quantitative data on studies' interventions were summarized in tables, pooled by different coronavirus species and strain, UV source, characteristics of UV light exposure and outcomes. Eighteen papers met our inclusion criteria, published between 1972 and 2020. Six focused on SARS-CoV-2, four on SARS-CoV-1, one on MERS-CoV, three on seasonal coronaviruses, and four on animal coronaviruses. All were experimental studies. Overall, despite wide heterogenicity within included studies, complete inactivation of coronaviruses on surfaces or aerosolized, including SARS-CoV-2, was reported to take a maximum exposure time of 15 min and to need a maximum distance from the UV emitter of up to 1 m. Advances in UV-based technologies in the field of sanitation and their proved high virucidal potential against SARS-CoV-2 support their use for IPC in hospital and community settings and their contribution towards ending the COVID-19 pandemic. National and international guidelines are to be updated and parameters and conditions of use need to be identified to ensure both efficacy and safety of UV technology application for effective infection prevention and control in both healthcare and non-healthcare settings.

Identifiants

pubmed: 34029626
pii: S0195-6701(21)00208-5
doi: 10.1016/j.jhin.2021.05.005
pmc: PMC8139389
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-78

Informations de copyright

Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Références

Infect Control Hosp Epidemiol. 2016 May;37(5):598-9
pubmed: 26818469
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Pathog Immun. 2020 Apr 20;5(1):52-67
pubmed: 32363254
BMC Infect Dis. 2020 Jan 29;20(1):82
pubmed: 31996170
Infect Control Hosp Epidemiol. 2021 Feb;42(2):127-130
pubmed: 32741425
Vet J. 2008 Jul;177(1):71-9
pubmed: 17513145
Int J Environ Res Public Health. 2019 Sep 24;16(19):
pubmed: 31554297
J Occup Environ Hyg. 2007 Jun;4(6):400-5
pubmed: 17474029
Public Health Rep. 2010 Jan-Feb;125(1):15-27
pubmed: 20402193
Appl Environ Microbiol. 1985 Jun;49(6):1361-5
pubmed: 2990336
Am J Infect Control. 2017 Nov 1;45(11):1208-1213
pubmed: 28757085
Proc Soc Exp Biol Med. 1972 Mar;139(3):722-7
pubmed: 5063367
Lancet. 2017 Feb 25;389(10071):805-814
pubmed: 28104287
J Hosp Infect. 2021 Apr;110:89-96
pubmed: 33453351
Am J Infect Control. 2015 Dec 1;43(12):1342-6
pubmed: 26277574
J Clin Virol. 2004 Jan;29(1):13-22
pubmed: 14675864
BMC Infect Dis. 2017 Oct 10;17(1):672
pubmed: 29017457
Am J Infect Control. 2019 Apr;47(4):406-408
pubmed: 30502111
J Infect Dis. 2020 Jun 29;222(2):214-222
pubmed: 32432672
BMC Infect Dis. 2018 Feb 23;18(1):91
pubmed: 29471796
Am Rev Respir Dis. 1989 May;139(5):1286-94
pubmed: 2653151
Health Phys. 2004 Aug;87(2):171-86
pubmed: 15257218
Am J Ind Med. 2006 Dec;49(12):1056-65
pubmed: 17096360
BMC Infect Dis. 2014 Apr 07;14:187
pubmed: 24708734
Radiat Res. 2017 Apr;187(4):483-491
pubmed: 28225654
Int J Health Sci (Qassim). 2020 Nov-Dec;14(6):52-65
pubmed: 33192232
Science. 1935 Sep 20;82(2125):280-1
pubmed: 17792965
Sao Paulo Med J. 2020 Nov-Dec;138(6):505-514
pubmed: 33206913
BMC Infect Dis. 2019 Jul 3;19(1):575
pubmed: 31269912
Photochem Photobiol. 2012 Jul-Aug;88(4):1001-4
pubmed: 22458545
Infect Control Hosp Epidemiol. 2006 Jul;27(7):729-34
pubmed: 16807849
Environ Sci Technol. 2016 Dec 20;50(24):13371-13379
pubmed: 27993065
ACS Nano. 2020 May 26;14(5):6348-6356
pubmed: 32368894
PeerJ. 2020 Oct 13;8:e10196
pubmed: 33083158
Gastrointest Endosc. 2020 Sep;92(3):519-523
pubmed: 32353457
J Photochem Photobiol B. 2020 Nov;212:112044
pubmed: 33022467
Ann Ig. 2015 May-Jun;27(3):562-79
pubmed: 26152543
Am J Infect Control. 2020 Oct;48(10):1273-1275
pubmed: 32763344
Photodiagnosis Photodyn Ther. 2020 Dec;32:101995
pubmed: 32916328
Free Radic Res. 2019 Jun;53(6):611-617
pubmed: 30947566
ScientificWorldJournal. 2014;2014:824538
pubmed: 25379545
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
J Ocul Pharmacol Ther. 2000 Jun;16(3):285-97
pubmed: 10872925
Front Microbiol. 2018 Feb 02;9:119
pubmed: 29456527
Rev Environ Health. 2020 Aug 26;36(2):193-198
pubmed: 32845869
Jikken Dobutsu. 1988 Jul;37(3):341-5
pubmed: 3416941
Clin Infect Dis. 2004 Sep 1;39(5):702-9
pubmed: 15356786
Anim Health Res Rev. 2011 Jun;12(1):15-23
pubmed: 21676338
ALTEX. 2019;36(1):3-17
pubmed: 30633302
Am J Infect Control. 2021 Mar;49(3):299-301
pubmed: 32896604
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):11875-11877
pubmed: 32404416
BMC Infect Dis. 2012 May 16;12:120
pubmed: 22591268
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
Curr Opin Pharmacol. 2013 Oct;13(5):731-62
pubmed: 24060701
Am J Infect Control. 2016 May 2;44(5 Suppl):e77-84
pubmed: 27131140
Lancet Infect Dis. 2018 Aug;18(8):845-853
pubmed: 29880301
Emerg Microbes Infect. 2020 Dec;9(1):1744-1747
pubmed: 32673522
Nat Commun. 2020 May 29;11(1):2800
pubmed: 32472043
Int J Food Microbiol. 2004 Jan 1;90(1):1-8
pubmed: 14672825
J Sci Food Agric. 2000 May 1;80(6):637-645
pubmed: 29345786
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6666-70
pubmed: 8341684
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Environ Sci Technol. 2007 Aug 1;41(15):5460-5
pubmed: 17822117
Infect Control Hosp Epidemiol. 2013 May;34(5):466-71
pubmed: 23571362
Pathogens. 2020 Sep 08;9(9):
pubmed: 32911671
Biophys J. 1965 May;5(3):257-73
pubmed: 19431332
J Virol Methods. 2004 Oct;121(1):85-91
pubmed: 15350737
Sci Rep. 2020 Jun 24;10(1):10285
pubmed: 32581288
Biomed Environ Sci. 2003 Sep;16(3):246-55
pubmed: 14631830
PLoS One. 2018 Jul 25;13(7):e0201259
pubmed: 30044862
Am J Infect Control. 2018 Jun;46(6):720-722
pubmed: 29550083
Arch Virol. 1981;68(3-4):239-47
pubmed: 7271457
Photochem Photobiol Sci. 2020 Oct 14;19(10):1262-1270
pubmed: 32812619
Anesth Analg. 2020 Jul;131(1):37-42
pubmed: 32217947
Dermatology. 2006;212 Suppl 1:119-23
pubmed: 16490989
Am J Infect Control. 2020 Nov;48(11):1370-1374
pubmed: 32512083
Am J Vet Res. 1977 Oct;38(10):1491-5
pubmed: 201184
Science. 1944 Feb 11;99(2563):130-1
pubmed: 17814296
Sci Rep. 2018 Feb 9;8(1):2752
pubmed: 29426899

Auteurs

F Chiappa (F)

School of Public Health, University Vita-Salute San Raffaele, Milan, Italy.

B Frascella (B)

School of Public Health, University Vita-Salute San Raffaele, Milan, Italy.

G P Vigezzi (GP)

School of Public Health, University Vita-Salute San Raffaele, Milan, Italy.

M Moro (M)

Infection Control Committee, IRCCS San Raffaele Hospital, Milan, Italy.

L Diamanti (L)

Clinical Engineering Unit, IRCCS San Raffaele Hospital, Milan, Italy; HTA Committee, IRCCS San Raffaele Hospital, Milan, Italy.

L Gentile (L)

Clinical Engineering Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

P Lago (P)

Clinical Engineering Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

N Clementi (N)

Laboratory of Microbiology and Virology, University Vita-Salute San Raffaele, Milan, Italy.

C Signorelli (C)

School of Medicine, University Vita-Salute San Raffaele, Milan, Italy.

N Mancini (N)

Laboratory of Microbiology and Virology, University Vita-Salute San Raffaele, Milan, Italy.

A Odone (A)

HTA Committee, IRCCS San Raffaele Hospital, Milan, Italy; Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy. Electronic address: anna.odone@unipv.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH